Home/Navigator Medicines/Scott Forrest, PhD
SF

Scott Forrest, PhD

Chief Financial Officer

Navigator Medicines

Navigator Medicines Pipeline

DrugIndicationPhase
NAV-240Autoimmune Diseases (unspecified)Phase 2a
NAV-242Inflammatory/Autoimmune DiseasesPhase 1